Area of research
Infectious Diseases · Animal Science and Zoology
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Viral Infections and Outbreaks Research, and Viral Infections and Vectors.
Engineering a Modular PapMV Nanoparticle Vaccine: Comparative Efficacy of a Covalent and a Non-Covalent N-Antigen Vaccine Against Emerging SARS-CoV-2 Variants.
Fusion protein pan-sarbecovirus vaccines elicit broadly protective immune responses targeting Clade 1a, 1b, and 3 sarbecoviruses
MERS-CoV and SARS-CoV-2 infection in diverse human lung organoid-derived cultures.
Bat-specific adaptations in interferon signaling and GBP1 contribute to enhanced antiviral capacity.
Developing Synthetic Full-Length SARS-CoV-2 cDNAs and Reporter Viruses for High-Throughput Antiviral Drug Screening.
Genome-wide Screening Identifies Unique Host-Directed Drugs and Pro-viral Signalling Pathways for SARS-CoV-2
Studying bats using a One Health lens: bridging the gap between bat virology and disease ecology
Studying bats using a One Health lens: bridging the gap between bat virology and disease ecology.
Construction and immunogenicity of SARS-CoV-2 virus-like particle expressed by recombinant baculovirus BacMam.
Bat-specific adaptations in interferon signaling and GBP1 contribute to enhanced viral tolerance
Regulatory dissection of the severe COVID-19 risk locus introgressed by Neanderthals
Generation of a SARS-CoV-2 Reverse Genetics System and Novel Human Lung Cell Lines That Exhibit High Virus-Induced Cytopathology.
N-Phenylpyridine-3-Carboxamide and 6-Acetyl-1H-Indazole Inhibit the RNA Replication Step of the Dengue Virus Life Cycle.
Previous infection with seasonal coronaviruses does not protect male Syrian hamsters from challenge with SARS-CoV-2.
Construction and Immunogenicity of SARS-CoV-2 Virus-like Particle Expressed by Recombinant Baculovirus BacMam
Generation of a SARS-CoV-2 reverse genetics system and novel human lung cell lines that exhibit high virus-induced cytopathology
Differential interferon-α subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection
Differential interferon-α subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection.
Feasibility of Polyclonal Avian Immunoglobulins (IgY) as Prophylaxis against Human Norovirus Infection
Feasibility of Polyclonal Avian Immunoglobulins (IgY) as Prophylaxis against Human Norovirus Infection.
Immunogenicity of convalescent and vaccinated sera against clinical isolates of ancestral SARS-CoV-2, Beta, Delta, and Omicron variants
SARS-CoV-2 Variant-Specific Infectivity and Immune Profiles Are Detectable in a Humanized Lung Mouse Model.
Thiopurines inhibit coronavirus Spike protein processing and incorporation into progeny virions
SARS-CoV-2 infection in the Syrian hamster model causes inflammation as well as type I interferon dysregulation in both respiratory and non-respiratory tissues including the heart and kidney.
Highly Specific Sigma Receptor Ligands Exhibit Anti-Viral Properties in SARS-CoV-2 Infected Cells.
Unique aspects of adaptive immunity in camelids and their applications.
Animal models for COVID-19
Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection.